Log in

VanEck Vectors Biotech ETF Stock Price, News & Analysis (NASDAQ:BBH)

$121.14
+0.66 (+0.55 %)
(As of 10/18/2019 02:36 AM ET)
Today's Range
$120.77
Now: $121.14
$121.42
50-Day Range
$114.66
MA: $120.59
$124.01
52-Week Range
$103.25
Now: $121.14
$132.80
Volume11,600 shs
Average Volume15,936 shs
Market Capitalization$326.71 million
P/E RatioN/A
Dividend Yield4.58%
Beta1.3

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Biotech ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BBH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Biotech 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$357.00 million
Average Daily Volume$23,202.10
Discount/Premium-0.09%

ETF Expenses

Management Fee0.35%
Other Expenses0.04%
Total Expenses0.39%
Fee Waiver-0.04%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerVirtu Financial

Receive BBH News and Ratings via Email

Sign-up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Currency Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Sector Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Industry Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)

VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions

What is VanEck Vectors Biotech ETF's stock symbol?

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

How often does VanEck Vectors Biotech ETF pay dividends? What is the dividend yield for VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF announced an annual dividend on Friday, November 16th. Investors of record on Friday, December 21st will be paid a dividend of $0.537 per share on Thursday, December 27th. This represents a yield of 0.44%. The ex-dividend date is Thursday, December 20th. View VanEck Vectors Biotech ETF's Dividend History.

Has VanEck Vectors Biotech ETF been receiving favorable news coverage?

Media stories about BBH stock have been trending somewhat negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. VanEck Vectors Biotech ETF earned a news impact score of -1.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for VanEck Vectors Biotech ETF.

Who are some of VanEck Vectors Biotech ETF's key competitors?

What other stocks do shareholders of VanEck Vectors Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Arlo Technologies (ARLO), International Game Technology (IGT), SPDR S&P 500 ETF Trust (SPY), Alliance MMA (AMMA), Ashford (AINC), Allied Healthcare Products (AHPI), Adobe (ADBE), B&M European Value Retail (BME), Anglo American (AAL) and Deutsche Bank (DBK).

Who are VanEck Vectors Biotech ETF's major shareholders?

VanEck Vectors Biotech ETF's stock is owned by many different of retail and institutional investors. Top institutional investors include Murphy Capital Management Inc. (1.38%) and North Star Investment Management Corp. (0.03%).

Which major investors are selling VanEck Vectors Biotech ETF stock?

BBH stock was sold by a variety of institutional investors in the last quarter, including Murphy Capital Management Inc..

Which major investors are buying VanEck Vectors Biotech ETF stock?

BBH stock was bought by a variety of institutional investors in the last quarter, including North Star Investment Management Corp..

How do I buy shares of VanEck Vectors Biotech ETF?

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is VanEck Vectors Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $121.14.

How big of a company is VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF has a market capitalization of $326.71 million. View Additional Information About VanEck Vectors Biotech ETF.


MarketBeat Community Rating for VanEck Vectors Biotech ETF (NASDAQ BBH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  68
MarketBeat's community ratings are surveys of what our community members think about VanEck Vectors Biotech ETF and other stocks. Vote "Outperform" if you believe BBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel